ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Recruiting · NCT04792892 · Observational (researchers observe without assigning treatment) · Lead sponsor: Sahlgrenska University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Anal cancer is a rare disease, but the incidence is rising. About 200 patients will get this type of cancer yearly in Sweden. Curative treatment includes chemotherapy and radiotherapy. The prognosis is good, but some patients will have recurrent or persistent disease after concluded chemo-radiotherapy and will then be offered salvage surgery. Some patients develop distant metastases that can be treated with good results. The aim of this study is to identify and describe functional outcome in patients diagnosed with anal cancer. We will study patients from diagnosis, try to identify early toxicity to treatment and then identify long-term morbidity.
Who can take part
Inclusion criteria
- Age \> 18 years
- Anal squamous carcinoma diagnosed within the last 2 months
Exclusion criteria
- No informed consent
Where it is running
1 location listed.
- Dept. of Surgery, Sahlgrenska University Hospital/Ostra - Gothenburg, Sweden